Cognition Therapeutics Inc SEC filings CGTX
Cognition Therapeutics Inc has 303 filings in SEC EDGAR's recent list, going back to Jan 29, 2009. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Dec 23, 2025 | — |
| CORRESP | Letter to the SEC | Dec 22, 2025 | — |
| EFFECT | Filing | Jan 8, 2024 | — |
| CORRESP | Letter to the SEC | Jan 4, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 3, 2024 | — |
| EFFECT | Filing | Jan 3, 2023 | — |
| CORRESP | Letter to the SEC | Dec 29, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 28, 2022 | — |
| EFFECT | Filing | Nov 9, 2022 | — |
| CORRESP | Letter to the SEC | Nov 7, 2022 | — |
| CORRESP | Letter to the SEC | Nov 7, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 24, 2022 | — |
| DRS | Filing | Oct 20, 2022 | — |
| EFFECT | Filing | Oct 7, 2021 | — |
| CERT | Filing | Oct 7, 2021 | — |
| 8-A12B | Form 8-a12b | Oct 6, 2021 | — |
| CORRESP | Letter to the SEC | Oct 5, 2021 | — |
| CORRESP | Letter to the SEC | Oct 5, 2021 | — |
| CORRESP | Letter to the SEC | Sep 10, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2021 | — |
| CORRESP | Letter to the SEC | Jul 29, 2021 | — |
| CORRESP | Letter to the SEC | Jul 29, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2021 | — |
| CORRESP | Letter to the SEC | Jul 19, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 2, 2021 | — |
| DRSLTR | Filing | Jun 23, 2021 | — |
| DRS/A | Filing | Jun 23, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2021 | — |
| DRS | Filing | May 7, 2021 | — |
| D | Filing | Nov 28, 2018 | — |
| D | Filing | Mar 15, 2018 | — |
| D/A | Filing | Jan 18, 2017 | — |
| D | Filing | Nov 30, 2016 | — |
| D | Filing | Mar 31, 2016 | — |
| D/A | Filing | Jul 22, 2015 | — |
| D/A | Filing | Apr 10, 2015 | — |
| D | Filing | Apr 1, 2014 | — |
| D/A | Filing | Sep 5, 2013 | — |
| D | Filing | Jan 3, 2013 | — |
| D | Filing | Dec 6, 2011 | — |
| D | Filing | Dec 28, 2010 | — |
| REGDEX | Auto-generated paper document | Jan 29, 2009 | — |
Showing 42 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CGTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Purchase, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1455365
- Former names
- COGNITION THERAPUTICS INC (until Dec 28, 2010)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.